SCHEMBL5681929

SCHEMBL5681929

CCOOP(=O)(OOCC)C(CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1)P(=O)(OOCC)OOCC

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.68
▸ ALDH1A1 P00352 3/20 0.68
▸ LMNA P02545 2/20 0.68
▸ HPGD P15428 2/20 0.68
▸ HSD17B10 Q99714 2/20 0.68
▸ MAPT P10636 1/20 0.68
▸ CYP1A2 P05177 1/20 0.56
▸ TOP2A P11388 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ TOP2B Q02880 1/20 0.56
▸ HRH3 Q9Y5N1 1/20 0.55
▸ PIK3CG P48736 3/20 0.52
▸ PIK3CD O00329 2/20 0.52
▸ PIK3R1 P27986 2/20 0.52
▸ PIK3CA P42336 2/20 0.52
▸ CA1 P00915 1/20 0.51
▸ CA2 P00918 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5679660 0.93 KDM4E (0.71) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL5681760 0.87 KDM4E (0.71) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL5680865 0.85 KDM4E (0.47) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL2157933 0.83 KDM4E (0.85) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL5007407 0.83 KDM4E (0.73) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL17350870 0.82 KDM4E (0.82) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL28556438 0.82 KDM4E (0.93) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL17554684 0.81 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL149150 0.81 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL29349852 0.81 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831869-B1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS IN (US) 2006-02-08 — — EP disclosed
EP-0831869-A4 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS IN (US) 1999-04-21 — — EP disclosed
EP-0831869-A1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS Elizanor Biopharmaceuticals, Inc. (US) 1998-04-01 — — EP disclosed
WO-1996040190-A1 DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1996-12-19 — — WO disclosed
Send feedback